Prolactinoma risk factors: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
==Risk factors== | ==Risk factors== | ||
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with: | [[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with: | ||
*Multiple endocrine neoplasia type I (MEN I) | *Multiple endocrine neoplasia type I (MEN I)<ref>http://radiopaedia.org/articles/pituitary-adenoma</ref> | ||
*Carney complex | *Carney complex | ||
*McCune-Albright Syndrome | *McCune-Albright Syndrome | ||
*MEN like syndrome ( CKDN1B loss of function) | *MEN like syndrome ( CKDN1B loss of function) | ||
So patients with any of these syndromes are at increased risk for prolactinoma. | So patients with any of these syndromes are at increased risk for prolactinoma. | ||
== References == | == References == | ||
Revision as of 18:53, 9 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Prolactinoma risk factors |
|
Risk calculators and risk factors for Prolactinoma risk factors |
Overview
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. So patients with any of these syndromes are at increased risk for prolactinoma.
Risk factors
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with:
- Multiple endocrine neoplasia type I (MEN I)[1]
- Carney complex
- McCune-Albright Syndrome
- MEN like syndrome ( CKDN1B loss of function)
So patients with any of these syndromes are at increased risk for prolactinoma.